If you would like to submit a blog post for consideration, please email email@example.com
In the blog category “Case Studies” Professor David Wilkinson offers an excellent platform to discuss clinical problems and cases within a closed alumni community. This area is password-protected and only accessible to past UQ Skin Cancer Certificate course participants.
We encourage you to submit clinical images and questions so we can all learn together.
This week, we have another wonderful case from Dr Slavko Doslo. A 65-year-old female presented for a skin check and a lesion was noticed as indicated. What is your assessment of the clinical and dermoscopic images? What would you do – if anything?
Drinking alcohol increases a person’s risk of developing non-melanoma skin cancer, according to a review published in British Journal of Dermatology. Previously, the association between alcohol intake and non-melanoma skin cancer – which mainly comprises of basal cell carcinoma and cutaneous squamous cell carcinoma – was inconclusive. Therefore, the objective of the recent review was […]
We know that dermoscopy provides us with more information than is possible with the naked eye. The trick is to understand what the additional information means, and what we should do with it! This is where research on dermoscopy and management guidelines is so important. In this case, we are particularly looking at the management […]
This week we have an interesting case from Dr Sanazsadat Hejazi. A 77-year-old female presented for a skin check and a lesion was noticed as indicated on left forearm. Here is a clinical picture of a rapidly growing (3 weeks) lesion in an elderly lady. What is the important differential diagnosis list here? How would you biopsy this?
A ‘groundbreaking’ immunotherapy drug is helping patients overcome advanced non-melanoma skin cancer. Cemiplimab is being used at Sir Charles Gaidner Hospital in Perth as part of an international trial. Oncologist Annette Lim, who runs the trial, says most patients have responded with encouraging results. There were strict criteria for patients to enter the trial, but […]
A new research centre in Brisbane will test a variety of products that claim to be sun safe. Queensland University of Technology (QUT) is partnering with Q-Pharm to open its Centre for Testing New Technology, which will test lotions, apps, patches and wearables, and any other products that promise to protect users from the sun.
This week, we have another interesting case from Dr Slavko Doslo. A 59-year-old male presented for a Skin check and a lesion was noticed. Unfortunately, we do not have the clinical images. The challenge this week is to describe the dermoscopic picture as we all know what the diagnosis will be.
Merkel cell carcinoma (MCC) is a rare, aggressive, and often fatal neuroendocrine skin cancer – the incidence of which has increased in recent decades. Early and recurrent MCC is managed very differently than other skin cancers. People at higher risk of developing Merkel cell carcinoma are typically those who have had multiple prior skin cancers […]
The US Food and Drug Administration has approved Novartis’ Tafinlar-Mekinist combination for use as a stage 3 melanoma treatment, just four months after the drug was approved for treatment of non-small cell lung cancer with a BRAF V600E mutation. The BRAF/MEK combination can now be used to treat this particular mutation after studies found that […]
This week, we have another wonderful case from Dr Slavko Doslo. A 77-year-old male presented for a skin check and a lesion was noticed as indicated. What is your assessment of the clinical and dermoscopic images? What would you do – if anything?